Contrasting OptimizeRx (NASDAQ:OPRX) and CompuGroup Medical SE & Co. KGaA (OTCMKTS:CMPUY)

CompuGroup Medical SE & Co. KGaA (OTCMKTS:CMPUY) and OptimizeRx (NASDAQ:OPRX) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, earnings, institutional ownership, analyst recommendations, risk and dividends.

Insider & Institutional Ownership

76.5% of OptimizeRx shares are held by institutional investors. 7.5% of OptimizeRx shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Profitability

This table compares CompuGroup Medical SE & Co. KGaA and OptimizeRx’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
CompuGroup Medical SE & Co. KGaA	N/A	N/A	N/A
OptimizeRx	4.66%	9.44%	7.11%

Earnings & Valuation

This table compares CompuGroup Medical SE & Co. KGaA and OptimizeRx”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CompuGroup Medical SE & Co. KGaA	N/A	N/A	N/A	N/A	N/A
OptimizeRx	$98.65 million	1.49	$5.13 million	$0.23	34.04

OptimizeRx has higher revenue and earnings than CompuGroup Medical SE & Co. KGaA.

Analyst Recommendations

This is a breakdown of current ratings and target prices for CompuGroup Medical SE & Co. KGaA and OptimizeRx, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CompuGroup Medical SE & Co. KGaA	0	0	0	0	0.00
OptimizeRx	1	2	6	0	2.56

OptimizeRx has a consensus target price of $11.43, indicating a potential upside of 45.96%. Given OptimizeRx’s stronger consensus rating and higher probable upside, analysts plainly believe OptimizeRx is more favorable than CompuGroup Medical SE & Co. KGaA.

Summary

OptimizeRx beats CompuGroup Medical SE & Co. KGaA on 9 of the 9 factors compared between the two stocks.

About CompuGroup Medical SE & Co. KGaA

CompuGroup Medical SE & Co. KGaA develops and sells software and information technology solutions for the healthcare sector worldwide. The company's Ambulatory Information Systems segment develop and sell practice management software for registered physicians, medical care centers, and physician networks; and offers supplementary internet and intranet solutions. Its Pharmacy Information Systems segment develop and sell administrative and billing related software applications, which includes procuring and shipping, managing and controlling inventory, planning, performing, and monitoring retail activities for pharmacies. Hospital Information Systems segment develop and sells of clinical and administrative solutions for inpatient sector; healthcare services to acute care hospitals, rehabilitation centers, welfare institutions, multi-location hospital networks, healthcare regions, regional care organizations, medical laboratories, and radiologists. The Consumer & Health Management Information Systems segment provides software interfaces for data exchange, portals for retrieving data from the German outpatient healthcare market, medical decision support tools, medication and treatment databases for healthcare service providers, solutions for the insurance industry, and digital healthcare applications, consumer portals, and mobile apps; and operates telematics infrastructure business, which offers secure links, as well as security solutions for service providers. The company was founded in 1987 and is headquartered in Koblenz, Germany.

About OptimizeRx

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.